CRISIL Intrinsic Value
CRISIL • Financial Services
Current Stock Price
₹3761.20
Primary Intrinsic Value
₹1267.68
Market Cap
₹2633 Cr
-21.5%
Downside
Median Value
₹2951.21
Value Range
₹1128 - ₹9403
Assessment
Trading Above Calculated Value
Safety Margin
-27.4%
CRISIL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1267.68 | ₹1014.14 - ₹1521.22 | -66.3% | EPS: ₹105.64, Sector P/E: 12x |
| Book Value Method | asset | ₹2931.43 | ₹2638.29 - ₹3224.57 | -22.1% | Book Value/Share: ₹3664.29, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹5417.14 | ₹4875.43 - ₹5958.85 | +44.0% | Revenue/Share: ₹5417.14, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹7522.40 | ₹6770.16 - ₹8274.64 | +100.0% | EBITDA: ₹1200.00Cr, EV/EBITDA: 5x |
| Simple DCF (5Y) | dcf | ₹9403.00 | ₹7522.40 - ₹11283.60 | +150.0% | CF Growth: 11.2%, Discount: 15% |
| PEG Ratio Method | growth | ₹1128.36 | ₹1015.52 - ₹1241.20 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1128.36 | ₹1015.52 - ₹1241.20 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹7522.40 | ₹6770.16 - ₹8274.64 | +100.0% | ROE: 30.1%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹2951.21 | ₹2656.09 - ₹3246.33 | -21.5% | EPS: ₹105.64, BVPS: ₹3664.29 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
CRISIL Intrinsic Value Analysis
What is the intrinsic value of CRISIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of CRISIL (CRISIL) is ₹2951.21 (median value). With the current market price of ₹3761.20, this represents a -21.5% variance from our estimated fair value.
The valuation range spans from ₹1128.36 to ₹9403.00, indicating ₹1128.36 - ₹9403.00.
Is CRISIL undervalued or overvalued?
Based on our multi-method analysis, CRISIL (CRISIL) appears to be trading above calculated value by approximately 21.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.52 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 30.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.96x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for CRISIL
Additional stock information and data for CRISIL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹765 Cr | ₹571 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹780 Cr | ₹617 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹456 Cr | ₹427 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹403 Cr | ₹355 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹501 Cr | ₹351 Cr | Positive Free Cash Flow | 8/10 |